A question kit for finding care
A guide to finding care, with room for doubt
A plain-language guide to checking a provider you found elsewhere, understanding the offer, and getting ready for a visit.
You found a name, an offer, or an ad. Before agreeing to anything, ask who will assess you, what is being offered, and who will make it.
Sermorelin prompts the pituitary’s release of growth hormone, one of our body’s chemical signals; that tiny gland sits below the brain.
Get your bearings →A question to take with you
Which problem would we be treating, and what makes sermorelin a fit for it?
The Food and Drug Administration (FDA), the US agency responsible for drug oversight, has approved no sermorelin product currently marketed in the US as of September 28, 2026.
A prescription and a pharmacy name still need checking. A polished page cannot answer those questions for you.
Evidence to keep in view
A compounded medicine is prepared for an order, rather than arriving as the finished product of a drug company.
Compounded products have no advance FDA review as of September 26, 2026, covering quality, benefit, or harm before patients receive them.
Found a provider elsewhere? Bring the take-along questions to that conversation. Leave space for answers, and for anything the clinician needs to check.
Open the take-along question sheet →